BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16619692)

  • 1. Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.
    Rochford R; Feuer G; Orem J; Banura C; Katongole-Mbidde E; Mwanda WO; Moormann A; Harrington WJ; Remick SC
    East Afr Med J; 2005 Sep; 82(9 Suppl):S155-60. PubMed ID: 16619692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burkitt's lymphoma: single-centre experience with modified BFM protocol.
    Harris E; Paneesha S; Jackson N; Jones L; Mahendra P
    Clin Lab Haematol; 2002 Apr; 24(2):111-4. PubMed ID: 11985557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the management of Burkitt's lymphoma.
    Levine AM
    Clin Lymphoma; 2002 Dec; 3 Suppl 1():S19-25. PubMed ID: 12521385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine: a targeted therapy for endemic Burkitt's lymphoma.
    Kurokawa M; Andela V; Ghosh S; Barreto JE; Harrington W
    East Afr Med J; 2005 Sep; 82(9 Suppl):S150-4. PubMed ID: 16619691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Burkitt's lymphoma in HIV-positive patients.
    Straus DJ
    Biomed Pharmacother; 1996; 50(9):447-50. PubMed ID: 8991116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkitt's lymphoma and previous AIDS-defining illnesses are not prognostic factors in AIDS-related non-Hodgkin's lymphoma.
    Stebbing J; Mandalia S; Palmieri C; Nelson M; Gazzard B; Bower M
    J Clin Oncol; 2005 Nov; 23(33):8538-40; author reply 8540-1. PubMed ID: 16293885
    [No Abstract]   [Full Text] [Related]  

  • 8. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma.
    Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K
    AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary ovarian Burkitt's lymphoma: a rare oncological problem in gynaecology: a review of literature.
    Stepniak A; Czuczwar P; Szkodziak P; Wozniakowska E; Wozniak S; Paszkowski T
    Arch Gynecol Obstet; 2017 Oct; 296(4):653-660. PubMed ID: 28770352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphoma.
    Lehmann C; Wyen C; Hoffmann C; Fätkenheuer G
    HIV Med; 2005 Jan; 6(1):51-3. PubMed ID: 15670254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of AIDS-related lymphoma.
    Levine AM
    Curr Opin Oncol; 2008 Sep; 20(5):522-8. PubMed ID: 19106654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lymphoma.
    Sullivan MP
    Cancer; 1975 Mar; 35(3 suppl):991-5. PubMed ID: 1089476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment.
    Colebunders R; Dohmen S; Van de Velde A; Pelgrom J; Hermans P
    Acta Clin Belg; 2001; 56(5):321-2. PubMed ID: 11770227
    [No Abstract]   [Full Text] [Related]  

  • 15. Burkitt's Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital.
    Sissolak G; Seftel M; Uldrick TS; Esterhuizen TM; Mohamed N; Kotze D
    J Glob Oncol; 2017 Jun; 3(3):218-226. PubMed ID: 28717763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant lymphoma in the HIV-positive patient.
    Meister A; Hentrich M; Wyen C; Hübel K
    Eur J Haematol; 2018 Jul; 101(1):119-126. PubMed ID: 29663523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-elemene against Burkitt's lymphoma via activation of PUMA mediated apoptotic pathway.
    Hu T; Gao Y
    Biomed Pharmacother; 2018 Oct; 106():1557-1562. PubMed ID: 30119230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable response of pediatric AIDS-related Burkitt's lymphoma treated by aggressive chemotherapy.
    Neumann Y; Toren A; Mandel M; Martinowitz U; Varon D; Ramot B; Ben-Bassat I; Rechavi G
    Med Pediatr Oncol; 1993; 21(9):661-4. PubMed ID: 8413000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic aspects of AIDS-associated non-Hodgkin's lymphoma.
    Knowles DM
    Curr Opin Oncol; 1993 Sep; 5(5):845-51. PubMed ID: 8218497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging HIV/AIDS. Burkitt's lymphoma.
    Munn S
    AIDS Patient Care STDS; 2002 Aug; 16(8):395-9. PubMed ID: 12227990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.